ArticleCureus2026
Association Between Serum Biochemical Parameters and Kidney Stone Disease: An Exploratory Analysis of the 2017-2018 National Health and Nutrition Examination Survey (NHANES).
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidney stone disease (KSD) is a multifactorial condition associated with individual and healthcare burden. Routine biochemical markers have yet to be fully explored for their association with KSD.
methodsThis is a retrospective analysis of cross-sectional data from the 2017-2018 National Health and Nutrition Examination Survey (NHANES). Those with a complete biochemical profile and kidney stone history data were included. Weighted multivariable regression analysis was utilized to adjust for confounding factors, and false discovery rate (FDR) correction was employed to account for multiple comparisons across biochemical markers.
resultsA total of 4,820 participants were included in our analysis, 477 of whom reported a history of kidney stones. The mean age was 49.48 ± 0.48 years. Serum bicarbonate was found to be significantly lower among those who reported a history of nephrolithiasis in comparison with those without in the unadjusted model (β = -0.320 mmol/L, P = 0.037), the model adjusted for age and sex (β = -0.301 mmol/L, P = 0.038), and the model adjusted for comorbidities (β = -0.340 mmol/L, P = 0.044). Following FDR, this association, however, did not remain significant across models (q = 0.296-0.352). Other biochemical parameters did not reach statistical significance for association with kidney stones in any model.
conclusionSerum bicarbonate levels demonstrated a modest, nominally significant inverse association with a history of nephrolithiasis, but this did not persist after correction for multiple comparisons and should be interpreted with caution given the cross-sectional design of this study. No other parameter showed a significant association with kidney stones. These findings, suggesting limited utility for single-time-point biochemical testing for stone risk assessment, should be considered exploratory and hypothesis-generating rather than conclusive evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.